**Core Concept**
The management of anaphylaxis involves administering epinephrine to counteract the severe systemic allergic reaction, characterized by vasodilation, smooth muscle contraction, and respiratory distress. Epinephrine acts by stimulating beta-adrenergic receptors, leading to bronchodilation, vasoconstriction, and increased cardiac output.

**Why the Correct Answer is Right**
The recommended dose of epinephrine in anaphylaxis is 0.3-0.5 mg administered intramuscularly (IM) every 5-15 minutes as needed. This dose is sufficient to counteract the systemic effects of anaphylaxis, including bronchospasm and hypotension. The IM route allows for rapid absorption and onset of action, while minimizing the risk of cardiac arrhythmias associated with intravenous (IV) administration.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because the dose of epinephrine is too low, which may not be sufficient to counteract the severe systemic effects of anaphylaxis.
**Option B:** This option is incorrect because the dose of epinephrine is too high, which may increase the risk of cardiac arrhythmias and other adverse effects.
**Option C:** This option is incorrect because the route of administration is incorrect; epinephrine should be administered intramuscularly, not subcutaneously.

**Clinical Pearl / High-Yield Fact**
In anaphylaxis, the goal of epinephrine administration is to restore adequate oxygenation and circulation. It is essential to repeat the dose every 5-15 minutes as needed, while also administering oxygen and other supportive measures.

**Correct Answer: D. 0.5 mg IM every 5-15 minutes as needed.**